Published on in CHOP News
Researchers at the Center for Applies Genomics (CAG) at Children’s Hospital of Philadelphia (CHOP) have revealed how variants of a gene responsible for packing and condensing genetic material present a novel cause for certain neurodevelopmental disorders. The findings were published today in Science Advances.
Many neurodevelopmental disorders classified as intellectual disabilities are linked to certain genetic variants. Despite this, the underlying molecular mechanism for most of these patients is unknown. In particular, several neurodevelopmental disorders have been linked to pathogenic variants in genes responsible chromatin remodeling, or the rearrangement of the structure of chromosomes that allows for the transcription of DNA into directions to carry out necessary functions of the cells in the body.
One of these genes responsible for encoding a chromatin remodeling complex is SMARCA5. While there was some preclinical evidence that variants of SMARCA5 may be associated with developmental changes, a specific disorder associated with such variants had never been described.
“Our study is the first to describe how certain germline mutations in SMARCA5 are responsible for a spectrum of neurodevelopmental delays,” said study leader Dong Li, PhD, a research scientist with CAG. “Apart from identifying patients with such germline variants for the first time, our extended translational modeling study efforts to determine the underlying functions for these variants further elucidated their clinical relevance.”
This current study reports on 12 patients (six males and six females) across 10 unrelated families. Clinical features that were similar across these patients included mild developmental delay as well as short stature and microcephaly.
“We used fruit flies to study the effects of losing the function of SMARCA5 and found that this led to smaller body size, reduced the complexity of sensory neuron processes, among other defects in the larvae,” Song said. “In adult flies, the neural knockdown caused decreased brain size and abnormal locomotor function, and mutated SMARCA5 was unable to rescue the cells from this loss of function.”
“Our findings expand the spectrum of neurodevelopmental disorders linked to chromatin remodeling genes,” said Hakon Hakonarson, MD, PhD, Director of the Center for Applied Genomics at CHOP and senior author of the study. “It is very likely that this group of genetic variants may be responsible for other neurodevelopmental disorders and should be a point of focus going forward.”
This work was supported by the Roberts Collaborative Functional Genomics Rapid Grant and Institutional Development Funds from CHOP, National Institutes of Health grants DP2 NS111996 and T32 HL07953, the Burroughs Wellcome Fund, the Undiagnosed Diseases Program Victoria from the Harbig Family Foundation and the Murdoch Children’s Research Institute, and the Victorian Government's Operational Infrastructure Support Program. Additional sequencing and analysis were provided by the Broad Institute of the Massachusetts Institute of Technology and Harvard Center for Mendelian Genomics and was funded by the National Human Genome Research Institute, the National Eye Institute, and the National Heart, Lung and Blood Institute grant UM1 HG008900 and in part by National Human Genome Research Institute grant R01 HG009141.
Li et al, “Pathogenic variants in SMARCA5, a chromatin remodeler, cause a range of syndromic neurodevelopmental features.” Sci Adv, online May 12, 2021. DOI: 10.1126/sciadv.abf2066.
Lewis-Smith et al, “Modelling seizures in the Human Phenotype Ontology according to contemporary ILAE concepts makes big phenotypic data tractable.” Epilepsia, online May 5, 2021. DOI: 10.1111/epi.16908.
Contact: Ben Leach, The Children’s Hospital of Philadelphia, 267-426-2857 or firstname.lastname@example.org